Buy the rumor, sell the news: after a 3 week rally, Optimer Pharmaceutical (OPTR -7.2%) sells...

|About: Optimer Pharmaceuticals, Inc. (OPTR)|By:, SA News Editor

Buy the rumor, sell the news: after a 3 week rally, Optimer Pharmaceutical (OPTR -7.2%) sells off hard after winning FDA approval for its antibiotic drug Dificid for treatment of Clostridium Difficel-Associated infections.